NAD+
$75
In stock
View productCognitive Peptides
The cognitive peptides category holds one product, NAD+, which is not a peptide; it is labeled for research use only and ships from the USA and Canada to addresses across the United States.
Shop by category
This category holds one product, NAD+, and NAD+ is not a peptide, as the questions below explain. On FDA's list of bulk substances nominated for 503A compounding, updated May 14, 2026, nicotinamide adenine dinucleotide (NAD) is in Category 1, the substances FDA is still evaluating.1 In October 2024, FDA said it was aware of compounders making intravenous products from food-grade NAD+ sold by repackagers.3 It reported adverse events after NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue, some needing medical treatment, and said those reactions are consistent with excessive endotoxins.4
The cognitive goal guide maps what published studies report, compound by compound, with evidence levels.
1 product
No products match these filters.
All categories
- Anti-Aging Peptides 10 products
- Growth Hormone Peptides 9 products
- Healing and Recovery Peptides 13 products
- Muscle Growth Peptides 12 products
- Sleep and Stress Peptides 5 products
- Weight Loss Peptides 10 products
- Collagen Peptides 1 product
- Sexual Health Peptides 2 products
- Hormone Therapy Peptides 1 product
- Post-Cycle Therapy (PCT) Peptides 1 product
- Reproductive Health Peptides 4 products
- Cognitive Peptides 1 product
- Peptide Supplies 7 products
Ordering facts
NAD+ ships from the USA and Canada to addresses across the United States, with delivery details on the shipping page. The returns page gives the return terms, and testing documents are listed on the lab results page as they become available. Bacteriostatic water and syringes are sold separately on the supplies page.
Frequently asked questions
Where can I purchase injectable NAD?
Not here as an injectable medicine. NAD+ is sold as a 500 mg vial labeled for research use only, and NAD+ is not an FDA-approved drug in the US.56 Health Canada's April 2026 warning about injectable peptides bought online named NAD+ among unauthorized products.7 For lab work, mixing and storage are covered on the NAD+ reconstitution page, and the vial itself is on the NAD+ product page.
Is NAD+ a peptide?
No. Its full name, as FDA's compounding list gives it, is nicotinamide adenine dinucleotide.1 That makes it a dinucleotide, while NHGRI defines a peptide as a short chain of amino acids, typically 2 to 50, joined by peptide bonds.2 It is sold in this shop next to the peptides and filed in this category by the catalog. The NAD+ education page covers what published research reports about it.
Is Semax in this category?
No. Semax is sold here but filed under no category, and Selank sits under sleep and stress. FDA's advisory committee reviewed semax in July 2026 for cerebral ischemia, migraine and trigeminal neuralgia.8 Trade press reported a narrow vote recommending it for the 503A bulks list; FDA must still act and go through rulemaking.9 FDA says it has no or limited safety information on semax for the proposed routes, and lacks important information on any safety issues when selank acetate is given to people.10
Sources
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026). US Food and Drug Administration, 2026.
- Peptide (Talking Glossary of Genomic and Genetic Terms). National Human Genome Research Institute (NIH), 2026.
- FDA reminds compounders to use ingredients suitable for sterile compounding (food-grade NAD+). U.S. Food and Drug Administration, 2024.
- Same source as 3: FDA reminds compounders to use ingredients suitable for sterile compounding (adverse event reports).
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act (updated March 21, 2025). U.S. Food and Drug Administration, 2025.
- Human Drug Compounding Laws. U.S. Food and Drug Administration, 2024.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm your health. Health Canada (Recalls and Safety Alerts), 2026.
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. US Food and Drug Administration, 2026.
- FDA Panel Backs 6 Peptides for Compounding (July 31, 2026). AJMC (The American Journal of Managed Care), 2026.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. US Food and Drug Administration, 2026.